Review





Similar Products

aidi injection  (Fuzheng Pharmaceutical Co Ltd)
86
Fuzheng Pharmaceutical Co Ltd aidi injection
Aidi Injection, supplied by Fuzheng Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aidi+injection/aidi+injection/pmc12856469-168-19-8
Average 86 stars, based on 1 article reviews
aidi injection - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
aidi injection  (Beyotime)
99
Beyotime aidi injection
Aidi Injection, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aidi+injection/DAPI/pm41430119-126-23-35
Average 99 stars, based on 1 article reviews
aidi injection - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
aidi injection  (KangLaiTe)
90
KangLaiTe aidi injection
Chinese herbal drugs reviewed
Aidi Injection, supplied by KangLaiTe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aidi+injection/aidi+injection/pmc11545508-429-10-45
Average 90 stars, based on 1 article reviews
aidi injection - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
aidi injection ad  (Fuzheng Pharmaceutical Co Ltd)
90
Fuzheng Pharmaceutical Co Ltd aidi injection ad
League tables of NMA estimates for each outcome. (A) ORR (upper right half) and improvement rate of KPS (lower left half). (B) 1-year OS rate (upper right half) and 2-year OS rate (lower left half). (C) Incidence of leukopenia (upper right half) and nausea/vomiting (left lower half). Note: <t>CKI,</t> compound <t>Kushen</t> <t>injection;</t> KA, Kangai injection; KLT, Kanglaite injection; NA, not available; OS, overall survival; RT, radiotherapy; SM, Shenmai injection; SQFZ, Shenqi Fuzheng injection. Each cell represents the RR between the treatment on the right versus the treatment on the left. For ORR and KPS improvement rate, an RR greater than 1 indicates that the treatment on the right is superior. In the case of OS and AEs, an RR smaller than 1 suggests that the treatment on the right is better. Cells with bold font and asterisks indicate a statistically significant difference. For example, in the first row of <xref ref-type=Fig. 2A , the first blue cell signifies that CKI+RT significantly outperformed RT in improving ORR (RR=1.49, 95 % CrI 1.21–1.86). " width="250" height="auto" />
Aidi Injection Ad, supplied by Fuzheng Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aidi+injection/aidi+injection/pmc10681939-52-5-19
Average 90 stars, based on 1 article reviews
aidi injection ad - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Chinese herbal drugs reviewed

Journal: Molecular Cancer

Article Title: Traditional Chinese medicine in treating upper digestive tract cancers

doi: 10.1186/s12943-024-02149-x

Figure Lengend Snippet: Chinese herbal drugs reviewed

Article Snippet: Seven of the 17 CHDs described in this section, including Aidi Injection (CEA, CA125, CA199, and CA242) [ , ], Modified Bazhen Tang [CEA, CA19-9, insulin-like growth factor 1 (IGF-1) and platelet endothelial cell adhesion molecule (PECAM-1)] [ ], Chanpi Ezhu Tang (CA19-9) [ ], Kanglaite Injection (CEA and CA19-9) [ ], Kuerle Hospital-prepared Decoction (CEA, CA19-9, CA125, CA242, and VEGF) [ ], Sanleng Ezhu Decoction (CA125, CA72-4, CEA, and VEGF) [ ], and The Second Hospital of Jiaxing-prepared Decoction (VEGF, TIMP1, and MMP-9) [ ], in combination with SOX regimen respectively exerted better effects in down-regulating serum levels of tumor markers than SOX regimen alone.

Techniques: Injection, Modification

League tables of NMA estimates for each outcome. (A) ORR (upper right half) and improvement rate of KPS (lower left half). (B) 1-year OS rate (upper right half) and 2-year OS rate (lower left half). (C) Incidence of leukopenia (upper right half) and nausea/vomiting (left lower half). Note: CKI, compound Kushen injection; KA, Kangai injection; KLT, Kanglaite injection; NA, not available; OS, overall survival; RT, radiotherapy; SM, Shenmai injection; SQFZ, Shenqi Fuzheng injection. Each cell represents the RR between the treatment on the right versus the treatment on the left. For ORR and KPS improvement rate, an RR greater than 1 indicates that the treatment on the right is superior. In the case of OS and AEs, an RR smaller than 1 suggests that the treatment on the right is better. Cells with bold font and asterisks indicate a statistically significant difference. For example, in the first row of <xref ref-type=Fig. 2A , the first blue cell signifies that CKI+RT significantly outperformed RT in improving ORR (RR=1.49, 95 % CrI 1.21–1.86). " width="100%" height="100%">

Journal: Integrative Medicine Research

Article Title: Chinese herbal injections in combination with radiotherapy for advanced pancreatic cancer: A systematic review and network meta-analysis

doi: 10.1016/j.imr.2023.101004

Figure Lengend Snippet: League tables of NMA estimates for each outcome. (A) ORR (upper right half) and improvement rate of KPS (lower left half). (B) 1-year OS rate (upper right half) and 2-year OS rate (lower left half). (C) Incidence of leukopenia (upper right half) and nausea/vomiting (left lower half). Note: CKI, compound Kushen injection; KA, Kangai injection; KLT, Kanglaite injection; NA, not available; OS, overall survival; RT, radiotherapy; SM, Shenmai injection; SQFZ, Shenqi Fuzheng injection. Each cell represents the RR between the treatment on the right versus the treatment on the left. For ORR and KPS improvement rate, an RR greater than 1 indicates that the treatment on the right is superior. In the case of OS and AEs, an RR smaller than 1 suggests that the treatment on the right is better. Cells with bold font and asterisks indicate a statistically significant difference. For example, in the first row of Fig. 2A , the first blue cell signifies that CKI+RT significantly outperformed RT in improving ORR (RR=1.49, 95 % CrI 1.21–1.86).

Article Snippet: The CHIs of interest included CKI, Aidi injection (AD), Huachansu injection (HCS), Tongguanteng injection (TGT), Yadanzi injection (YDZ), Shenqi Fuzheng injection (SQFZ), Polyporus umbellatus polysaccharide injection (PUP), Kangai injection (KA), Kanglaite injection (KLT), Astragalus polysaccharide injection (APS), and Shenmai injection (SM).

Techniques: Injection

Rank-heat plot. Note: CKI, compound Kushen injection; KA, Kangai injection; KLT, Kanglaite injection; NA, not available; OS, overall survival; RT, radiotherapy; SQFZ, Shenqi Fuzheng injection; SM, Shenmai injection. The numbers represent SUCRA values. A higher SUCRA value indicates improved ORR, enhanced KPS, extended OS, and reduced incidence of leukopenia and nausea/vomiting.

Journal: Integrative Medicine Research

Article Title: Chinese herbal injections in combination with radiotherapy for advanced pancreatic cancer: A systematic review and network meta-analysis

doi: 10.1016/j.imr.2023.101004

Figure Lengend Snippet: Rank-heat plot. Note: CKI, compound Kushen injection; KA, Kangai injection; KLT, Kanglaite injection; NA, not available; OS, overall survival; RT, radiotherapy; SQFZ, Shenqi Fuzheng injection; SM, Shenmai injection. The numbers represent SUCRA values. A higher SUCRA value indicates improved ORR, enhanced KPS, extended OS, and reduced incidence of leukopenia and nausea/vomiting.

Article Snippet: The CHIs of interest included CKI, Aidi injection (AD), Huachansu injection (HCS), Tongguanteng injection (TGT), Yadanzi injection (YDZ), Shenqi Fuzheng injection (SQFZ), Polyporus umbellatus polysaccharide injection (PUP), Kangai injection (KA), Kanglaite injection (KLT), Astragalus polysaccharide injection (APS), and Shenmai injection (SM).

Techniques: Injection